Mercurial > repos > genouest > openlabcds2csv
view test-data/Report_Ex1.txt @ 1:91fa8b697e6a draft default tip
"planemo upload commit efc6f0fdf414834e1275781106dcfe291b7ffd0a"
author | genouest |
---|---|
date | Fri, 29 Oct 2021 14:23:46 +0000 |
parents | 9072a2d2178b |
children |
line wrap: on
line source
Data File C:\Chemstation\1\Data\211011_Corentin-Younes 2021-10-11 15-56-48\Std 500.D Sample Name: EX1 MPSr-GCFID 10/19/2021 2:39:33 PM SYSTEM ===================================================================== Acq. Operator : SYSTEM Seq. Line : 8 Sample Operator : SYSTEM Acq. Instrument : MPSr-GCFID Location : 6 (F) Injection Date : 10/11/2021 11:03:47 PM Inj : 1 Inj Volume : 1 µl Acq. Method : C:\Chemstation\1\Data\211011_Corentin-Younes 2021-10-11 15-56-48\190314_ Glucides_prep_12-110.M Last changed : 2/25/2021 3:02:59 PM by SYSTEM Analysis Method : C:\Chemstation\1\Data\211011_Corentin-Younes 2021-10-11 15-56-48\190314_ Glucides_retraitement.M Last changed : 10/19/2021 2:39:30 PM by SYSTEM (modified after loading) Additional Info : Peak(s) manually integrated ===================================================================== Internal Standard Report ===================================================================== Sorted By : Signal Calib. Data Modified : 10/15/2021 5:02:32 PM Multiplier : 1.0000 Dilution : 1.0000 Sample Amount: : 100.00000 [ng/ul] (not used in calc.) Use Multiplier & Dilution Factor with ISTDs Sample ISTD Information: ISTD ISTD Amount Name # [ng/ul] ----|-------------|------------------------- 1 100.00000 Adonitol Signal 1: FID1 A, RetTime Type ISTD Area Amt/Area Amount Grp Name [min] used [pA*s] ratio [ng/ul] -------|------|----|----------|----------|----------|--|------------------ 8.335 MF 1 10.97505 5.42183 531.23458 Glyoxylate 9.925 FM 1 19.37573 3.36334 581.78554 Glycolate 13.462 BB 1 22.58038 2.65118 534.44585 Succinate 13.765 BB 1 27.60959 2.21601 546.21713 Glycerate Totals without ISTD(s) : 1.95262e4 1 Warnings or Errors : Warning : Calibration warnings (see calibration table listing) ===================================================================== *** End of Report ***